People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Faeth Therapeutics, Inc. | — | Biotechnology | Series B | $24.4M | $109.3M | 2025 |
Stephen Hahn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Hahn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alex Morgan | 1 | 10 |
| Robert Gould | 1 | 3 |
| Jayson Dallas | 1 | 2 |
| Anand Parikh | 1 | 2 |
| Oliver Maddocks | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.